Catheter ablation of polymorphic ventricular tachycardia/fibrillation in patients with and without structural heart
Tomofumi Nakamura1, Benjamin Schaeffer2, Shinichi Tanigawa2
1Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Background:
Catheter ablation for polymorphic ventricular tachycardia and ventricular fibrillation (PMVT/VF) may target triggering premature ventricular contractions (PVCs). Targeting ventricular scar has also been suggested, but data are limited.
Objective:
The purpose of this study was to characterize the electrophysiological findings and ablation outcomes for patients with PMVT/VF and structural heart disease (SHD) compared to those with idiopathic VF.
Methods:
Data from 32 consecutive patients (13 idiopathic VF, 19 SHD) with recurrent PMVT/VF who underwent catheter ablation were reviewed.
Results:
A low-voltage area of myocardial scar was present in 15 of 19 patients with SHD. Sustained monomorphic ventricular tachycardia (SMVT) associated with scar was inducible and targeted in 8, 3 of whom had previous SMVT episodes separate from PMVT/VF episodes and 5 had no history of SMVT. Triggering PVCs were identified in 11 patients and arose from an area of endocardial scar in 6. Only scar ablation was performed in 8 patients who did not have triggering PVCs. All idiopathic VF patients underwent PVC ablation only. During a median of 540 days, 74% of SHD patients and 77% of idiopathic VF patients were free of recurrence, including 75% of those with only PVC ablation, 86% of those with scar plus PVC ablation, and 63% of those with only scar ablation.
Conclusion:
Patients with recurrent PMVT/VF and SHD often have a low-voltage scar associated with PVCs or inducible SMVT, which may also be the substrate for PMVT/VF. When present, substrate ablation targeting scar is a reasonable option for treatment of PMVT/VF even if PVCs are absent.
Insights
Catheter ablation for polymorphic ventricular tachycardia (PMVT/VF) can target premature ventricular contractions (PVCs) or myocardial scar. Scar ablation is effective for PMVT/VF in structural heart disease patients, even without identifiable PVCs.
Area of Science:
- Electrophysiology
- Cardiology
- Cardiac Ablation
Background:
- Catheter ablation for polymorphic ventricular tachycardia and ventricular fibrillation (PMVT/VF) often targets premature ventricular contractions (PVCs).
- The role of targeting ventricular scar in PMVT/VF ablation is less understood due to limited data.
Purpose of the Study:
- To compare electrophysiological findings and ablation outcomes in patients with PMVT/VF and structural heart disease (SHD) versus idiopathic ventricular fibrillation (VF).
- To evaluate the efficacy of targeting ventricular scar in PMVT/VF ablation.
Main Methods:
- Retrospective review of 32 consecutive patients with recurrent PMVT/VF undergoing catheter ablation.
- Patients were categorized into idiopathic VF (n=13) and SHD (n=19) groups.
- Ablation strategies included targeting PVCs, ventricular scar, or both.
Main Results:
- Myocardial scar was present in 15 of 19 SHD patients.
- Triggering PVCs originated from scar in 6 patients.
- Recurrence-free rates were 74% for SHD and 77% for idiopathic VF patients.
- Patients undergoing scar plus PVC ablation had an 86% recurrence-free rate.
Conclusions:
- Recurrent PMVT/VF in SHD patients is often associated with myocardial scar, which can serve as the substrate.
- Substrate ablation targeting scar is a viable treatment option for PMVT/VF, even in the absence of identifiable PVCs.
- Combined scar and PVC ablation demonstrated high efficacy.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Rheumatic Heart Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Anatomy of the Heart
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...


